Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. NewAmsterdam Pharma Company NV shares valued at $84,203 were purchased by Topper James N on Mar 04 ’25. At $21.02 per share, Topper James N acquired 4,005 shares. The insider’s holdings grew to 3,012,434 shares worth approximately $71.03 million following the completion of this transaction.
Also, Kooij Louise Frederika sold 150,000 shares, netting a total of over 3,055,500 in proceeds. Following the sale of shares at $20.37 each, the insider now holds 15,000 shares.
Before that, Kooij Louise Frederika had added 150,000 shares to its account. In a trade valued at $3,040,500, the Officer bought NewAmsterdam Pharma Company NV shares for $20.27 each.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, NewAmsterdam Pharma Company NV [NAMS] has been a Buy and the price target has been revised to $48. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. As of March 14, 2024, Scotiabank has initiated its “Sector outperform” rating for NAMS. Earlier on January 18, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for NAMS stock.
Analyzing NAMS Stock Performance
During the last five days, there has been a surge of approximately 0.34%. Over the course of the year, NewAmsterdam Pharma Company NV shares have dropped approximately -8.25%. Shares of the company reached a 52-week high of $26.80 on 01/02/25 and a 52-week low of $17.18 on 02/25/25. A 50-day SMA is recorded $22.17, while a 200-day SMA reached $19.90.
Support And Resistance Levels for NewAmsterdam Pharma Company NV (NAMS)
According to the 24-hour chart, there is a support level at 22.78, which, if violated, would cause prices to drop to 21.98. In the upper region, resistance lies at 24.12. The next price resistance is at 24.66. RSI (Relative Strength Index) is 62.05 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.68, which suggests the price will increase in the coming days. Percent R is at 9.22%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
